{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:34:05Z","timestamp":1774074845636,"version":"3.50.1"},"reference-count":45,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,10,8]],"date-time":"2004-10-08T00:00:00Z","timestamp":1097193600000},"content-version":"vor","delay-in-days":2747,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[1997,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The plasma membrane dopamine transporter (DAT) is considered to be a reliable marker of presynaptic dopaminergic terminal loss. Previous in vivo imaging and postmortem binding studies have detected a loss in striatal DAT binding in Parkinson's diseased (PD) brain; however, these techniques have poor spatial resolution and may suffer from nonspecific binding of some ligands. In this study, we use novel highly specific monoclonal antibodies to distinct epitopes of human DAT to quantify and localize the protein. Western blot analysis revealed marked reductions in DAT immunoreactivity in putamen, caudate, and nucleus accumbens of PD brain compared with control cases, and the reductions were significantly correlated to disease duration. Immunohistochemistry revealed DAT\u2010immunoreactive fibers and puncta that were dense throughout the striatum of control brains but that were drastically reduced in putamen of PD brains. Caudate from PD brains showed a significant degree of sparing along the border of the ventricle, and the nucleus accumbens was relatively preserved. An unexpected finding was that discrete islands of DAT immunoreactivity were preserved within the matrix of PD putamen. Thus, immunological analysis of DAT protein provides novel and sensitive means for localizing and quantifying DAT protein in PD and other neurological disorders involving dopaminergic systems.<\/jats:p>","DOI":"10.1002\/ana.410410417","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T14:58:49Z","timestamp":1104591529000},"page":"530-539","source":"Crossref","is-referenced-by-count":167,"title":["Immunochemical analysis of dopamine transporter protein in Parkinson's disease"],"prefix":"10.1002","volume":"41","author":[{"given":"Gary W.","family":"Miller","sequence":"first","affiliation":[]},{"given":"Julie K.","family":"Staley","sequence":"additional","affiliation":[]},{"given":"Craig J.","family":"Heilman","sequence":"additional","affiliation":[]},{"given":"Jeffrey T.","family":"Perez","sequence":"additional","affiliation":[]},{"given":"Deborah C.","family":"Mash","sequence":"additional","affiliation":[]},{"given":"David B.","family":"Rye","sequence":"additional","affiliation":[]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2004,10,8]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"19","article-title":"Biochemical pathology of Parkinson's disease","volume":"45","author":"Hornykiewicz O","year":"1986","journal-title":"Adv Neurol"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198804073181402"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(90)90033-D"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1948034"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1948035"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024295422944"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(92)90220-6"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(94)90029-9"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350421"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(92)90099-N"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410370306"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1987.tb02908.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90278-6"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.47.237"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000117168"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb02580.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1990.00530120034007"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1990.tb00926.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410340331"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890090107"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00501873"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90281-9"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.24.11965"},{"key":"e_1_2_1_25_2","first-page":"1263","article-title":"PET studies on brain monoamine transporters with carbon\u201011\u2010\u03b2\u2010CIT in Parkinson's disease","volume":"36","author":"Laihinen AO","year":"1995","journal-title":"J Nucl Med"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380407"},{"key":"e_1_2_1_27_2","first-page":"125","article-title":"Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H] WIN 35,428 and [3H] GBR 12,935 binding","volume":"45","author":"Pristupa ZB","year":"1994","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199203000-00007"},{"key":"e_1_2_1_29_2","first-page":"1224","article-title":"[3H] WIN 34,428 ([3H]CFT) binds to multiple charge\u2010states of the solubilized dopamine transporter in primate striatum","volume":"273","author":"Gracz LM","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(87)90002-1"},{"key":"e_1_2_1_31_2","first-page":"421","article-title":"Binding of the cocaine analog 2B\u2010[3H] carbomethoxy\u20103B\u2010(4\u2010fluorophenyl)tropane to the serotonin transporter","volume":"40","author":"Rudnick G","year":"1991","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.3.718"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.03-01-00001.1983"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-03-01714.1995"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.19.8861"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380114"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.9.4350"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(81)90131-7"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.7.1051"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-02-00436.1996"},{"key":"e_1_2_1_41_2","first-page":"34","article-title":"Early stage loss of dopamine uptake\u2010site binding in MPTP\u2010treated monkeys","volume":"60","author":"Graybiel AM","year":"1993","journal-title":"Adv Neurol"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)90182-1"},{"key":"e_1_2_1_43_2","first-page":"111","article-title":"The dopaminergic nigropallidal projection in primates: distinct cellular origin and relative sparing in MPTP\u2010treated monkeys","volume":"53","author":"Parent A","year":"1990","journal-title":"Adv Neurol"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(94)90124-4"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.5.1071"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)90012-4"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.410410417","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.410410417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:10:58Z","timestamp":1698473458000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.410410417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["10.1002\/ana.410410417"],"URL":"https:\/\/doi.org\/10.1002\/ana.410410417","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}